臨床婦人科産科67巻8号

2013年08月発行

今月の臨床 婦人科がんの予防戦略と早期診断 子宮体がん

2．月経異常患者の子宮体がん予防

著者： 宮本強¹ 塩沢丹里¹

所属機関： ¹信州大学医学部産婦人科学講座

ページ範囲：P.805 - P.812

●子宮体がんにおいては月経異常がリスク因子であり，月経異常はun-opposed estrogen状態を反映している．

●体がん予防効果のエビデンスがあるのが経口避妊薬（OC）である．

参考文献

1） Henderson BE, Feigelson HS : Hormonal carcinogenesis. Carcinogenesis 21 : 427─433, 2000

2） Potischman N, Hoover RN, Brinton LA, et al : Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 88 : 1127─1135, 1996

3） Allen NE, Key TJ, Dossus L, et al : Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition（EPIC）. Endocr Relat Cancer 15 : 485─497, 2008

4） Lépine J, Audet-Walsh E, Grégoire J, et al : Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways. J Clin Endocrinol Metab 95 : 2689─2698, 2010

5） Audet-Walsh E, Lépine J, Grégoire J, et al : Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients : association with risk and relationship to clinical characteristics. J Clin Endocrinol Metab 96 : E330─339, 2011

6） Soliman PT, Oh JC, Schmeler KM, et al : Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 105 : 575─580, 2005

7） Haidopoulos D, Simou M, Akrivos N, et al : Risk factors in women 40 years of age and younger with endometrial carcinoma. Acta Obstet Gynecol Scand 89 : 1326─1330, 2010

8） Iatrakis G, Zervoudis S, Saviolakis A, et al : Women younger than 50 years with endometrial cancer. Eur J Gynaecol Oncol 27 : 399─400, 2006

9） Xu WH, Xiang YB, Ruan ZX, et al : Menstrual and reproductive factors and endometrial cancer risk : Results from a population-based case-control study in urban Shanghai. Int J Cancer 108 : 613─619, 2004

10） Matias-Guiu X, Catasus L, Bussagilla E, et al : Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol 32 : 569─577, 2001

11） Ellenson LH : Endometrial cancer. In : The genetic basis of human cancer. 2nd ed（Vogelstein B, Kinzler KW eds）. p681─688, McGraw-Hill, New York, 2002

12） Lax SF : Molecular genetic pathways in various types of endometrial carcinoma : from a phenotypical to a molecular-based classification. Virchows Arch 444 : 213─223, 2004

13） Miyamoyo T, Shiozawa T, Kashima H, et al : Estrogen up-regulates mismatch repair activity in normal and malignant endometrial glandular cells. Endocrinology 147 : 4863─4870, 2006

14） Santen RJ, Allred DC, Ardoin SP, et al : Endocrine Society. Postmenopausal hormone therapy : an Endocrine Society scientific statement. J Clin Endocrinol Metab 95（7 Suppl 1） : s1─s66, 2010

15） Weiss NS, Sayvetz TA : Incidence of endometrial cancer in relation to the use of oral contraceptives. N Engl J Med 302 : 551─554, 1980

16） Hannaford PC, Iversen L, Macfarlane TV, et al : Mortality among contraceptive pill users : cohort evidence from Royal College of General Practitioners’ Oral Contraception Study. BMJ 340 : c927, 2010

17） Vessey M, Yeates D, Flynn S : Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. Contraception 82 : 221─229, 2010

18） Dossus L, Allen N, Kaaks R, et al : Reproductive risk factors and endometrial cancer : the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 127 : 442─451, 2010

19） Schlesselman JJ : Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis. Hum Reprod 12 : 1851─1863, 1997

20） La Vecchia C, Altieri A, Franceschi S, et al : Oral contraceptives and cancer : an update. Drug Saf 24 : 741─754, 2001

21） Gallos ID, Shehmar M, Thangaratinam S, et al : Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia : a systematic review and metaanalysis. Am J Obstet Gynecol 547 : e1─10, 2003

22） Somboonporn W, Panna S, Temtanakitpaisan T, et al : Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women : systematic review and meta-analysis. Menopause 18 : 1060─1066, 2011

23） Brown AJ, Westin SN, Broaddus RR, et al : Progestin intrauterine device in an adolescent with grade 2 endometrial cancer. Obstet Gynecol 119（2 Pt 2） : 423─426, 2012

24） Wan YL, Holland C : The efficacy of levonorgestrel intrauterine systems for endometrial protection : a systematic review. Climacteric 14 : 622─632, 2011

25） Schouten LJ, Goldbohm RA, van den Brandt PA : Anthropometry, physical activity, and endometrial cancer risk : results from the Netherlands Cohort Study. J Natl Cancer Inst 96 : 1635─1638, 2004

26） Trentham-Dietz A, Nichols HB, Hampton JM, et al : Weight change and risk of endometrial cancer. Int J Epidemiol 35 : 151─158, 2006